Active ingredient
Plazomicin
3 finished FDA listings contain Plazomicin as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- PLAZOMICIN, PLAZOMICIN SULFATE
- Dosage forms
- Injection
- Routes
- Intravenous
- Manufacturers / labelers
- 3
- Strengths listed
- 500 mg/10ml
- Brand names in FDA listings
- Zemdri (Plazomicin)
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 2049549
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 210303 | CIPLA USA | 2018-06-25 | 3 |
Official labeling on DailyMed
- ZEMDRI (PLAZOMICIN) (PLAZOMICIN) INJECTION [CIPLA USA INC.] · version 4 · 2024-12-23
- ZEMDRI (PLAZOMICIN) (PLAZOMICIN) INJECTION [CIPLA THERAPEUTICS INC.] · version 2 · 2023-02-28
- ZEMDRI (PLAZOMICIN) (PLAZOMICIN) INJECTION [ACHAOGEN, INC.] · version 1 · 2018-07-16
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.